Joyce Zandra Singer MD

Recommended Articles

• The Risks of Oxycodone for Fibromyalgia Patients

  Fibromyalgia is difficult to identify, diagnose, and treat. Its symptoms are strikingly similar to other diseases that cause excessive fatigue, stress, and depression. People without the disease normally do not understand it. However, awareness around the disease is slowly improving.In the past,...

• Survey Shows 'Invisible' Aspects of Rheumatoid Arthritis Are Difficult to Explain

  According to Health Union’s most recent survey, “Rheumatoid Arthritis in America”, over 85% of patients (8 in 10) diagnosed with rheumatoid arthritis struggle to explain “invisible” symptoms. “RA symptoms can be caused by a variety of other conditions. In my case, I had a badly swollen...

• In Sickness and In Health: Fibromyalgia and Marriage

  Navigating the ups and downs of a chronic illness is difficult. Patients can experience roadblocks and dead ends that can disrupt their daily lives. Disorders, like fibromyalgia, are very difficult to manage, especially when getting a diagnosis can take months, or sometimes years.  Thankfully,...

• Rheumatoid Arthritis's Impact on the Lungs and How to Protect Them

  Rheumatoid arthritis’s causes are poorly understood by the medical community, but that doesn’t mean that patients shouldn’t be proactive in managing their RA and working to prevent flares.Patients with RA should also be aware that it does not just affect their bones and joints. This autoimmune...

• Understanding Peripheral Neuropathy in Adult Lupus Patients

  Systemic Lupus Erythematosus (SLE) is an autoimmune disease that has been affecting millions of people, both young and old worldwide. Numerous studies about this disease have been conducted by different academic, pharmaceutical, and medical organizations. Over the course of continuous and extensive...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...